BioInvent Announces Publication of Data in Leading Cancer Journal Immunity

Go back to BioInvent Announces Publication of Data in Leading Cancer Journal Immunity
(NYSE: BINV) Delayed: 43.17 --0 (-0%)
Previous Close $43.17    52 Week High $ 
Open $43.17    52 Week Low $ 
Day High $43.17    P/E N/A 
Day Low $43.17    EPS $ 
Volume 1,052